In 2005, the first GLP-1 got FDA approval to manage type 2 diabetes due to its ability to keep blood sugar stable, with others soon following
GLP-1RAs can cross the bloodbrain barrier and activate brain GLP-1 receptors, leading to neuroprotection by improving insulin signaling, reducing tau hyperphosphorylation, and enhancing cognitive function in diabetic and aging models
Recommended Storage Temperature Compounded semaglutide should be stored properly to maintain its potency
Semaglutide acts on the hypothalamus, a part of the brain that you could think of similar to a thermostat that controls more than just the body temperature
GLP-1 medications affect more than just your weight
High-intensity exercise shifts fuel utilization toward glycogen, reducing the advantage of the pre-mobilized fatty acids